Abstract:Exposure to chronic stress, including early life adverse experiences, has long-lasting effects on brain structure and functions and it is associated with a higher risk for psychiatric disorders, such as major depression, later in life. Human and rodent studies have indeed demonstrated that chronic stress during sensitive developmental periods impacts multiple biological processes, causing alterations in the neuroimmune system, including microglia, and in stress response mechanisms. Indeed, long-term effects of chronic stress on immune functions are usually associated with a low grade inflammation in combination with persistent disruptions in the hypothalamic-pituitary- adrenal (HPA) axis. In this context, childhood trauma represents one of the main early life stress event that can cause alterations in such previously mentioned biological processes and, therefore, it can contribute to the onset of major depression later on. It has also been associated with a lack of response to antidepressant drugs. Although the contribution of chronic stress in the development of major depression has been quite extensively described, there is a great need to further understand the affected mechanisms and to dissect the consequences of their alterations at central and peripheral levels. This might lead to the identification of novel biomarkers and to the development of new intervention strategies useful to stop or delay the onset of clinical symptoms and to predict/improve the treatment response. Moreover, this might be helpful in the differential diagnosis of major depression, identifying specific biomarkers able to differentiate depressed subjects from other psychiatric patients. By using a multidisciplinary approach, our symposium will cover these important issues. Indeed, from a preclinical and clinical perspective, we will provide evidence about the involvement of novel biomarkers, i.e. SGK1 and FKBP5, in major depression and we will give a clearer picture about the role of microglia in depressed patients with a history of childhood trauma. Moreover, by using a cross-tissues approach, spanning from post-mortem brains, cerebrospinal fluid (CSF) and peripheral blood, we will try to identify a biomarker profile specifically associated with the development of major depression and with a lack of response to antidepressant drugs. Finally, our symposium will highlight how a multidisciplinary approach focused on different expertise and experimental techniques, including methylation, gene expression, immunofluorescence and proteomics data, can increase the knowledge about the long-term impact of chronic stress in major depression.

Stress induced neural reorganization: A conceptual framework linking depression and Alzheimer's disease

Chronic stress and Alzheimer's disease: the interplay between the hypothalamic-pituitary-adrenal axis, genetics and microglia

Influence of gut microbiota on resilience and its possible mechanisms

Hypothalamic-Pituitary-Adrenal (HPA) Axis: Unveiling the Potential Mechanisms Involved in Stress-Induced Alzheimer's Disease and Depression

The Role of Chronic Stress in Anxious Depression

Chronic stress as a risk factor for Alzheimer’s disease

Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress

Revisiting the Stress Concept: Implications for Affective Disorders

Increased neural activity relates to greater neuropsychiatric symptoms and beta‐amyloid plaque load in cognitively normal older adults

Sleep and circadian rhythm disruption and stress intersect in Alzheimer's disease

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer's disease

The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology

Chronic Stress-Induced Neuroinflammation: Relevance of Rodent Models to Human Disease

Neurobiological Links between Stress, Brain Injury, and Disease

The multiple roles of chronic stress and glucocorticoids in Alzheimer's disease pathogenesis

A neural model of vulnerability and resilience to stress-related disorders linked to differential susceptibility

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments

Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories

Deciphering prefrontal circuits underlying stress and depression: exploring the potential of volume electron microscopy

Stress molecular signaling in interaction with cognition

The long-term impact of stress exposure at central and peripheral level: novel biomarkers to identify intervention strategies in major depression